Quantifying Heterogeneity in Tumors: Proposing a New Method Utilizing Convolutional Neuronal Networks.

Area of Science:

• Oncology
• Medical Imaging
• Computational Biology

Background:

• Glioblastoma (GBM) exhibits significant heterogeneity, contributing to poor patient survival.
• Current methods for quantifying GBM heterogeneity are not clinically applicable or cost-efficient.
• Addressing heterogeneity is crucial for improving glioblastoma treatment outcomes.

Purpose of the Study:

• To present a novel, cost-efficient method for quantifying glioblastoma heterogeneity using artificial intelligence.
• To establish a tool for integrated diagnosis by incorporating image analysis with clinical and mutational data.
• To explore the potential application of this method in precision medicine for brain tumors.

Main Methods:

• Digitization of glioblastoma tumor samples.
• Utilization of two convolutional neural networks (CNNs): one for GBM delimitation and another for heterogeneity quantification.
• Integration of image analysis with potential incorporation of clinical data and mutational status.

Main Results:

• The developed method successfully quantifies heterogeneity within glioblastoma tumors.
• Convolutional neural networks demonstrate the ability to interpret complex image data and identify hidden patterns.
• The approach shows promise for a more integrated diagnostic process.

Conclusions:

• This novel CNN-based method offers a promising tool for quantifying glioblastoma heterogeneity.
• The approach has the potential to advance precision medicine by enabling integrated diagnosis.
• The methodology may be adaptable for assessing heterogeneity in other tumor types.